Literature DB >> 4117099

Monoclonal IgG gammopathy and hyperparathyroidism.

R N Dexter, F Mullinax, H L Estep, R C Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4117099     DOI: 10.7326/0003-4819-77-5-759

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

2.  Parathyroid adenoma and light chain myeloma.

Authors:  R C Chisholm; Y J Weaver; E B Chung; J L Townsend
Journal:  J Natl Med Assoc       Date:  1981-09       Impact factor: 1.798

3.  Hypercalcaemia due to the coexistence of parathyroid adenoma and myelomatosis.

Authors:  R M Francis; A G Bynoe; C Gray
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

4.  Hypercalcaemia due to hyperparathyroidism in a patient with chronic renal failure and renal carcinoma.

Authors:  J J Szwed; L J Gott; R E Lempke; I S Seo
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

5.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

Review 6.  [Hypocalcemia in malignant diseases].

Authors:  E Heidbreder; K Schafferhans; A Heidland
Journal:  Klin Wochenschr       Date:  1983-08-15

Review 7.  Effects of parathyroid hormone on immune function.

Authors:  Abdallah Sassine Geara; Mario R Castellanos; Claude Bassil; Georgia Schuller-Levis; Eunkue Park; Marianne Smith; Michael Goldman; Suzanne Elsayegh
Journal:  Clin Dev Immunol       Date:  2010-09-16

Review 8.  Cytokines in Endocrine Dysfunction of Plasma Cell Disorders.

Authors:  Eva Feigerlová; Shyue-Fang Battaglia-Hsu
Journal:  Mediators Inflamm       Date:  2017-06-27       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.